HYPERSTEALTH
Generate Biomedicines, Inc.
Application Filed: 2021-05-07
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90696222 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | F08292000600 |
Timeline
| 2021-05-07 | Application Filed |
| 2021-07-26 | Status: Live/Pending |
| 2021-08-09 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Generate Biomedicines, Inc. |
| Address | 55 Cambridge Parkway, Suite 800E Cambridge DE 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2021-05-07 |
 Drawing | JPEG | 2021-05-07 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Biological and chemical agents for scientific and research use; pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-09 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2022-01-12 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-01-12 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2022-01-12 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-01-12 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-07-01 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-07-01 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-07-01 | 8 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2022-07-05 | 9 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2022-07-05 | 10 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-07-05 | 11 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2022-07-05 | 12 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-07-05 | 13 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-07-20 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-08-09 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-08-09 | 16 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-10-04 | 17 NOAM E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-11-22 | 18 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-22 | 19 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-22 | 20 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-22 | 21 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-11-22 | 22 CHAN I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2023-03-30 | 23 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-03-30 | 24 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-03-30 | 25 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-04-01 | 26 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-09-15 | 27 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2023-09-15 | 28 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2023-09-15 | 29 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-09-19 | 30 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-03-13 | 31 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2024-03-13 | 32 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2024-03-13 | 33 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-03-14 | 34 EXRA E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HYPERSTEALTH 90696222 not registered Live/Pending |
Generate Biomedicines, Inc. 2021-05-07 |
 HYPERSTEALTH 75731216 2965416 Live/Registered |
HYPERSTEALTH BIOTECHNOLOGY CORP. 1999-06-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 